Join
Live feed
·
INSIDERFilingvia Quantisnow
Precision BioSciences Inc. logo

President and CEO Amoroso Michael converted options into 67,797 shares and sold $78,947 worth of shares (20,559 units at $3.84), increasing direct ownership by 24% to 243,392 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DTIL· Precision BioSciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DTIL (Precision BioSciences Inc.) and more on Quantisnow.